• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性肝细胞癌中雄激素高亲和力结合位点的表征

Characterisation of high affinity binding sites of androgens in primary hepatocellular carcinoma.

作者信息

Wilkinson M L, Iqbal M J, Williams R

出版信息

Clin Chim Acta. 1985 Oct 31;152(1-2):105-13. doi: 10.1016/0009-8981(85)90181-0.

DOI:10.1016/0009-8981(85)90181-0
PMID:2414040
Abstract

The reported presence of androgen receptors (AR) in hepatocellular carcinoma (HCC) and foetal liver, but not in normal adult human liver, has been followed by further study of AR employing a new microassay. Tissues examined were: 5 samples of HCC with surrounding normal liver in 3 cases; 5 samples of cirrhotic liver and a single specimen of HCC in a child. High affinity binding of 5 alpha-dihydrotestosterone (DHT) was detected in cytosol (11.5-21 fmol/mg, Kd 1.5 X 10(-10)-3.1 X 10(-11) mol/l) and in nucleosol (8.7-11.4 fmol/mg, 6.7-1.4 X 10(-11) mol/l) of the 5 HCC samples. All other liver samples exhibited non-specific binding only. Competition studies indicated that DHT, testosterone, androstenedione, 5 alpha-androstan-3 beta, 17 beta-diol, androst-5-ene-3 beta,17 beta-diol and cyproterone acetate were acting at the same receptor binding site, relative displacement of 3H-DHT being 100, 85.7, 77.4, 67.8, 34.5 and 60.2 per cent respectively. Presence of 3.5S cytosolic and both 2.8S and 4S nucleosolic receptor patterns were demonstrated in both prostatic and HCC tissue. These studies confirm the presence of a cytosolic and nucleosolic androgen receptor in HCC which possesses similar characteristics to the AR of human prostate.

摘要

据报道,在肝细胞癌(HCC)和胎儿肝脏中存在雄激素受体(AR),而在正常成人肝脏中不存在,随后采用一种新的微量测定法对AR进行了进一步研究。所检查的组织包括:3例HCC患者的5份伴有周围正常肝脏的样本;5份肝硬化肝脏样本以及1例儿童HCC标本。在5份HCC样本的胞质溶胶(11.5 - 21飞摩尔/毫克,解离常数1.5×10⁻¹⁰ - 3.1×10⁻¹¹摩尔/升)和核溶胶(8.7 - 11.4飞摩尔/毫克,6.7 - 1.4×10⁻¹¹摩尔/升)中检测到5α - 双氢睾酮(DHT)的高亲和力结合。所有其他肝脏样本仅表现出非特异性结合。竞争研究表明,DHT、睾酮、雄烯二酮、5α - 雄烷 - 3β,17β - 二醇、雄甾 - 5 - 烯 - 3β,17β - 二醇和醋酸环丙孕酮作用于同一受体结合位点,3H - DHT的相对取代率分别为100%、85.7%、77.4%、67.8%、34.5%和60.2%。在前列腺组织和HCC组织中均证实存在3.5S胞质溶胶受体以及2.8S和4S核溶胶受体模式。这些研究证实了HCC中存在胞质溶胶和核溶胶雄激素受体,其具有与人类前列腺AR相似的特征。

相似文献

1
Characterisation of high affinity binding sites of androgens in primary hepatocellular carcinoma.原发性肝细胞癌中雄激素高亲和力结合位点的表征
Clin Chim Acta. 1985 Oct 31;152(1-2):105-13. doi: 10.1016/0009-8981(85)90181-0.
2
Androgen binding in peripheral tissues of fetal rhesus macaques: effects of androgen metabolism in liver.
J Steroid Biochem Mol Biol. 1990 Nov 30;37(4):545-51. doi: 10.1016/0960-0760(90)90399-6.
3
Effect of androgens and their manipulation on cell growth and androgen receptor (AR) levels in AR-positive and -negative human hepatocellular carcinomas.雄激素及其调控对AR阳性和阴性人肝细胞癌中细胞生长及雄激素受体(AR)水平的影响
J Hepatol. 1995 Mar;22(3):295-302. doi: 10.1016/0168-8278(95)80282-7.
4
Relative binding affinity of anabolic-androgenic steroids: comparison of the binding to the androgen receptors in skeletal muscle and in prostate, as well as to sex hormone-binding globulin.合成代谢雄激素类固醇的相对结合亲和力:与骨骼肌和前列腺中的雄激素受体以及性激素结合球蛋白的结合比较。
Endocrinology. 1984 Jun;114(6):2100-6. doi: 10.1210/endo-114-6-2100.
5
Preponderance of serum and intra-hepatic 5 alpha-dihydrotestosterone in males with hepatocellular carcinoma despite low circulating androgen levels.尽管循环雄激素水平较低,但肝细胞癌男性患者血清和肝内5α-双氢睾酮含量仍占优势。
J Hepatol. 1986;3(3):304-9. doi: 10.1016/s0168-8278(86)80482-2.
6
Androgen binding in nuclear matrix of human genital skin fibroblasts from patients with androgen insensitivity syndrome.雄激素不敏感综合征患者生殖器皮肤成纤维细胞核基质中的雄激素结合
J Clin Endocrinol Metab. 1986 Mar;62(3):542-50. doi: 10.1210/jcem-62-3-542.
7
Three-month treatment with a long-acting gonadotropin-releasing hormone agonist of patients with benign prostatic hyperplasia: effects on tissue androgen concentration, 5 alpha-reductase activity and androgen receptor content.长效促性腺激素释放激素激动剂对良性前列腺增生患者进行三个月治疗:对组织雄激素浓度、5α-还原酶活性及雄激素受体含量的影响
J Clin Endocrinol Metab. 1989 Feb;68(2):461-8. doi: 10.1210/jcem-68-2-461.
8
[Significance of both nuclear and cytosol androgen receptor (AR) in assessment of AR status in prostate carcinoma and hepatocellular carcinoma].
Ai Zheng. 2003 Feb;22(2):168-70.
9
Sex steroid receptor proteins in foetal, adult and malignant human liver tissue.胎儿、成人及恶性人肝组织中的性类固醇受体蛋白
Br J Cancer. 1983 Dec;48(6):791-6. doi: 10.1038/bjc.1983.268.
10
Androgen receptor in human liver: characterization and quantitation in normal and diseased liver.人肝脏中的雄激素受体:正常和患病肝脏中的特征与定量分析
Hepatology. 1994 Jan;19(1):92-100.

引用本文的文献

1
Dairy consumption and hepatocellular carcinoma risk.乳制品消费与肝细胞癌风险。
Ann Transl Med. 2021 Apr;9(8):736. doi: 10.21037/atm-2020-ubih-06.
2
The androgen receptor as an emerging target in hepatocellular carcinoma.雄激素受体作为肝细胞癌的一个新兴靶点。
J Hepatocell Carcinoma. 2015 Jun 26;2:91-9. doi: 10.2147/JHC.S48956. eCollection 2015.
3
Role of sex steroid receptors in pathobiology of hepatocellular carcinoma.性类固醇受体在肝细胞癌病理生物学中的作用。
World J Gastroenterol. 2008 Oct 21;14(39):5945-61. doi: 10.3748/wjg.14.5945.
4
Promotion of murine hepatocarcinogenesis by testosterone is androgen receptor-dependent but not cell autonomous.睾酮对小鼠肝癌发生的促进作用是雄激素受体依赖性的,但不是细胞自主性的。
Proc Natl Acad Sci U S A. 1989 Oct;86(19):7505-9. doi: 10.1073/pnas.86.19.7505.
5
Androgen receptor in hepatocellular carcinoma as a prognostic factor after hepatic resection.肝细胞癌中的雄激素受体作为肝切除术后的一个预后因素
Ann Surg. 1989 Apr;209(4):424-7. doi: 10.1097/00000658-198904000-00006.
6
Advances in neoplastic disease of the liver and biliary tract.肝脏和胆道肿瘤性疾病的进展
Gut. 1991 Sep;Suppl(Suppl):S104-10. doi: 10.1136/gut.32.suppl.s104.
7
Quantitation of estrogen and androgen receptors in hepatocellular carcinoma and adjacent normal human liver.肝细胞癌及相邻正常人体肝脏中雌激素和雄激素受体的定量分析。
Dig Dis Sci. 1991 Sep;36(9):1303-8. doi: 10.1007/BF01307527.